CSPC Innovation Pharmaceutical announced that on December 7, 2024, the company received a notice from the Shenzhen Stock Exchange regarding the acceptance of the application for issuing shares to purchase assets and raise supporting funds submitted by CSPC Innovation Pharmaceutical. The Shenzhen Stock Exchange has verified the application documents submitted by the company and deemed them complete, deciding to accept them.
新诺威：发行股份购买资产并募集配套资金申请获受理
Cspc innovation pharmaceutical: The application for issuing shares to purchase assets and raise supporting funds has been accepted.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.